Droxia Articles
B-MS South Africa deal for AIDS program
7 September 1999
More Competition In Hydroxyurea Market
6 August 1998
B-MS' Droxia OKed For Sickle Cell
5 March 1998
B-MS Receives Droxia OK From FDA Panel
2 January 1998
Showing 1-5 of 5 articles
- 1
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
